COVID-19 pandemic has increased mental health burden on family and friends of patients

Family members and close friends of people with COVID-19 have elevated symptoms of depression and anxiety, a study from Karolinska Institutet published in The Lancet Regional Health – Europe reports.

Digital games show promise for improving ADHD and depression in youth, but anxiety remains a challenge

A meta-analysis reveals gamified digital mental health interventions effectively reduce depression and ADHD in youth, highlighting engagement in treatment.

September 27, 2024

Atezolizumab Consolidation Impresses in High-Risk DLBCL

Postchemotherapy consolidation with atezolizumab (Tecentriq) led to a surprisingly high 2-year disease-free survival (DFS) in high-risk diffuse large B-cell lymphoma (DLBCL), a prospective nonrandomized trial

June 15, 2024

No Single Antipsychotic Offers Cognitive Benefit in Schizophrenia Disorders

No individual antipsychotic was associated with better cognitive outcomes than placebo in patients with schizophrenia spectrum disorders (SSD), according to a systematic review and network

October 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.